June 26th, 2019
•A method for establishing afatinib-resistance cell lines from lung adenocarcinoma PC-9 cells was developed, and resistant cells were characterized. The resistant cells can be used to investigate epidermal growth factor receptor tyrosine kinase inhibitor-resistance mechanisms, applicable for patients with non-small cell lung cancer.
Related Videos
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Analysis of Side Population in Solid Tumor Cell Lines
Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved